Immunotherapy: RAPID ACCESS TO VIRUS-SPECIFIC T CELLS FOR ADOPTIVE IMMUNOTHERAPY FOR COMPASSIONATE USE IN AUSTRALIAMichelle A. Neller, Rajiv Khanna, Stuart Best et al.|Cytotherapy|2023Cited by 0
Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2Andrea Henden, Corey Smith, K. Lineburg et al.|Cytotherapy|2023Cited by 0